Notably, NAPRT expression is often downregulated in several human cancers with EMT-like features, including gastric cancer (GC) 21, colorectal cancer (CRC), and pancreatic cancer (PAAD) (Figure 3B). Here, NAPRT is linked to gastric cancer.